Amgen

Open: 265.34 Close: 262.82 Change: -2.52

The stock market through the eyes of an AI: Amgen.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, Futures, Inc, price, quote, news, and the most common words in the summary are: amgen, stock, market, price, pdf, kb, notice, . One of the sentences in the summary was: (amgn) stock price, quote & news - stock analysis. Other searches related to this …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen Inc. (amgn) stock price, quote & news - stock analysis. Amgen stock +0.62% in premarket trade, after the biotech blew past earnings estimates for the third quarter. Board of Directors declared a $2.13 per cent dividend.

Today's News

Amgen Inc. (amgn) stock price, quote, news & analysis. amgen inc. (Amgn) (amgen inc.) stock falls t Tuesday, underperforms market. S&P Futures 4,561.50 +10.25 (+10.00%) Dow Futures 35,172.00 +24.00 (+0.07%) Nasdaq Futures 16,054.25 +64.00 (-64.50%) Crude Oil 75.70 -2.07 (-2.66%) Gold 2,003.90 +2.30 +0.13. Amgen stopped developing acapatamab in the summer of 2022. Amgen took a $650 million net impairment charge in relation to the axing of AMG 340, dragging down its earnings. Amgen will present data from two late-breaking abstracts at the European Society for Medical Oncology (ESMO) Congress 2023. Results from Amgen-sponsored and collaborative studies will feature data. Amgen completed its largest acquisition in company history on Oct. 31. Amgen: With return forecast of 9.2%, Abbott Laboratories is a better bet. Stelara Biosimilar Tests Value Proposition in Drug Price Program. Biotech star checked out early from career at Amgen. Undergrad Intern Amgen North Carolina (Summer 2024) Be part of Amgens newest and most advanced drug substance manufacturing plant. FleX Batch facility will combine the latest in disposable technologies with traditional stainless steel equipment. Amgen jobs - Director Manufacturing Support in Holly Springs, North Carolina, United States. Amgen FleX batch facility will combine latest in single use technologies with traditional stainless steel equipment. Amgen is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin or disability status. Amgen Inc. (amgn) stock price, quote & news - stock analysis. Amgen stock +0.62% in premarket trade, after the biotech blew past earnings estimates for the third quarter. Amgen announces $2.13 per share dividend for the fourth quarter of 2023. Board of Directors declared a $2.13 per cent dividend.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, Futures, Inc, price, quote, news, and the most common words in the summary are: amgen, stock, market, price, pdf, kb, notice, . One of the sentences in the summary was: (amgn) stock price, quote & news - stock analysis. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #price #pdf #kb #notice.